We are live on
!
Find out more
BS
Boenning & Scattergood Portfolio holdings
AUM
$622M
1-Year Est. Return
8.79%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
-8.79%
3 Year Est. Return
+34.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$574M
AUM Growth
+$48.9M
(+9.3%)
Cap. Flow
+$18.8M
Cap. Flow
% of AUM
3.27%
Top 10 Holdings %
Top 10 Hldgs %
23.38%
Holding
387
New
26
Increased
148
Reduced
108
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$14.4M |
| 2 |
Artesian Resources
ARTNA
|
+$1.71M |
| 3 |
Citigroup
C
|
+$1.11M |
| 4 |
IBM
IBM
|
+$889K |
| 5 |
Ballast Small/Mid Cap ETF
MGMT
|
+$829K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$999K |
| 2 |
Automatic Data Processing
ADP
|
+$933K |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$782K |
| 4 |
CVS Health
CVS
|
+$741K |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$698K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.18% |
| 2 | Healthcare | 14.64% |
| 3 | Financials | 10.82% |
| 4 | Industrials | 8.7% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Salesforce
CRM
$151B
| $548K | 0.1% |
2,242
-720
| -24% | -$166K |
|
227
BP
BP
$116B
| $543K | 0.09% |
20,541
-718
| -3% | -$18.8K |
|
228
PPG Industries
PPG
$24.6B
| $543K | 0.09% |
3,196
| – | – |
|
229
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $541K | 0.09% |
10,060
+1,220
| +14% | +$65.9K |
|
230
Flex
FLEX
$41.7B
| $537K | 0.09% |
39,903
| – | – |
|
231
Digital Realty Trust
DLR
$69.7B
| $535K | 0.09% |
3,556
| – | – |
|
232
Hain Celestial
HAIN
$45M
| $531K | 0.09% |
13,234
| – | – |
|
233
Dow Inc
DOW
$21.9B
| $527K | 0.09% |
8,328
+241
| +3% | +$15.9K |
|
234
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
| $526K | 0.09% |
2,226
+124
| +6% | +$27.8K |
|
235
iShares Morningstar US Equity ETF
ILCB
$1.27B
| $522K | 0.09% |
8,597
+2,577
| +43% | +$152K |
|
236
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
| $519K | 0.09% |
11,101
| – | – |
|
237
Thermo Fisher Scientific
TMO
$213B
| $517K | 0.09% |
1,025
+60
| +6% | +$28.3K |
|
238
Cigna
CI
$73.7B
| $515K | 0.09% |
2,173
+1
| +0% | +$250 |
|
239
Oracle
ORCL
$374B
| $514K | 0.09% |
6,605
-4,114
| -38% | -$322K |
|
240
Franco-Nevada
FNV
$41.1B
| $512K | 0.09% |
3,530
| – | – |
|
241
iShares Russell 1000 Value ETF
IWD
$82.2B
| $512K | 0.09% |
3,226
+1,075
| +50% | +$170K |
|
242
First Industrial Realty Trust
FR
$8.73B
| $510K | 0.09% |
9,756
| – | – |
|
243
Novartis
NVS
$297B
| $501K | 0.09% |
5,496
| – | – |
|
244
Zimmer Biomet
ZBH
$18.2B
| $497K | 0.09% |
3,186
-257
| -7% | -$41.6K |
|
245
Consolidated Edison
ED
$40.1B
| $486K | 0.08% |
6,774
+75
| +1% | +$5.76K |
|
|
SWN
246
DELISTED
Southwestern Energy Company
SWN
| $483K | 0.08% |
85,100
| – | – |
|
247
Pool Corp
POOL
$6.75B
| $482K | 0.08% |
1,051
| – | – |
|
248
McCormick & Company Non-Voting
MKC
$13.7B
| $479K | 0.08% |
5,420
-950
| -15% | -$84.7K |
|
249
OceanFirst Financial
OCFC
$1.68B
| $476K | 0.08% |
+22,837
| New | +$511K |
|
|
WBA
250
DELISTED
Walgreens Boots Alliance
WBA
| $473K | 0.08% |
8,998
-625
| -6% | -$33.6K |
|
Similar funds
AAM
F
GBS
C
FPCM
TC
SAS
PIM
Boenning & Scattergood's Q2 2021 Portfolio in Review
As of Q2 2021, Boenning & Scattergood held 387 positions worth $574M, up 9.3% from $525M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Boenning & Scattergood deployed $18.8M of net new capital in Q2 2021, opening 26 new positions and adding to 148 existing holdings. Its largest new stake was Schwab Short-Term US Treasury ETF: 562,742 shares worth $14.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $999K trimmed.
- Boenning & Scattergood's largest Q2 2021 buy was Schwab Short-Term US Treasury ETF: 562,742 shares worth $14.4M.
- Boenning & Scattergood added most to Artesian Resources in Q2 2021, an estimated $1.71M increase.
- Boenning & Scattergood's biggest Q2 2021 reduction was Gilead Sciences, cutting an estimated $999K.
- Boenning & Scattergood fully exited Rite Aid Corporation in Q2 2021, selling an estimated $782K.
- Boenning & Scattergood's ten largest holdings make up 23% of its $574M portfolio in Q2 2021.
- Boenning & Scattergood opened 26 new positions and closed 13 in Q2 2021.
- Boenning & Scattergood's portfolio value rose 9.3% quarter-over-quarter to $574M.
Based on Boenning & Scattergood's 13F filing for Q2 2021, filed 21 Jul 2021.